Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast Cream 0.3% in Plaque Psoriasis in China
NCT06648772Phase 3Completed
- Sponsor
- Huadong Medicine
- Start
- Nov 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roflumilast vehicle cream in plaque psoriasis, sponsored by Huadong Medicine. Started Nov 2024; status: completed.
02
Drugs
roflumilast vehicle cream
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06648772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06648772.